In treatment of bacterial meningitis, the assessment of the potential therapeutic efficacy of an antibiotic has generally been made by determination of drug concentrations in the cerebrospinal fluid (CSF) after parenteral administration of the drug in the presence of inflamed meninges. The defined goal is to exceed the in vitro minimal inhibitory concentration or minimal bactericidal concentration (MBC) of the infecting organism (15, 24, 27, 30) . However, several authors have noted that CSF antibiotic levels do not uniformly correlate with either clinical cure or failure of response (3, 19, 26, 30) . It is known that 33 to 50% of CSF formation is extrachoroidal, the bulk of this being derived from passage through the interstitial substance of the brain (4, 5, 22) . Moellering and Fischer have documented the clinical significance of differences between ventricular and lumbar CSF levels (17) , thus lending support to the importance of extrachoroidal CSF formation. Finally, histological examination has revealed microabscesses in the cerebral substance, documenting extension of meningitis beyond the leptomeninges in cases that have failed to respond to antibiotics (1, 23) . Because of all of these poorly understood features of meningitis and its therapy, we measured siimultaneously the drug concentrations in blood, brain, and CSF, utilizing several antibiotics and a rabbit model previously described (20) . Reported here are the results of experiments analyzing cefamandole, a new cephalosporin antibiotic. A comparison with several other antibiotics of known or questioned value for the treatment of meningitis is made.
MATERIALS AND METHODS
Adult, male New Zealand white rabbits weighing 2.0 to 3.5 kg were anesthetized by a slow intravenous infusion of 30 mg of Diabutal (sodium pentobarbital) per kg, administered via a peripheral ear vein. A cisternal puncture was performed with a 20-gauge needle and a 1.0-ml tuberculin syringe; 0.5 ml of CSF was withdrawn. If visible blood contamination resulted, the animal was not included in the study. A type III pneumococcus obtained from a child with otitis media was passed five times intraperitoneally in mice and five times intracisternally in rabbits. After overnight growth on 5% sheep blood agar (Baktron), this organism was suspended in phosphate-buffered saline (PBS), adjusted to 1.7 x 109 to 4.0 x 109 colony-forming units per ml, and injected via the same needle used for the cisternal tap. Gentle reaspiration and injection were performed to insure intracisternal inoculation. The needle was withdrawn, and the animal was returned to its cage for 18 h.
The animals were then treated for the designated time interval with cefamandole (kindly supplied by Eli Lilly & Co., Indianapolis, Ind., lot no. CT-2083-4D), ampicillin (Bristol Laboratories, Syracuse, N. Y., lot no. J6M11), penicillin G CSF and brain tissue were corrected for contamination with blood by measurement of hemoglobin concentration after the method of Lowry and Hastings (14) and a calculation utilizing hematocrit. For the assay of brain and CSF antibiotic levels, a culture of B. subtilis was diluted 1:20, and the agar was added to a petri dish (150 by 15 mm; Fisher Scientific Co., Pittsburgh, Pa.). This modification increased the sensitivity of antibiotic detection to the following levels (in namograms per milliliter): cefamandole, 50; cephalothin, 200; ampicillin, 200; tobramycin, 50; and penicillin G, 50. CSF or brain values reported below these limits resulted when the following levels (in nanograms per milliliter): ing blood was subtracted from the experimentally determined concentrations.
A standard curve was included on each plate. Two animals receiving no antibiotic infusion and not infected with pneumococci plus two animals infected but untreated were sacrificed; samples of serum, brain, and CSF were obtained as previously outlined. No inhibitory effect of any ofthese samples was documented by the agar-well diffusion technique utilized. Similarly, standards were prepared in serum, CSF, and brain homogenate from these animals and compared with standards made in PBS. No statistically significant differences were noted. Therefore, standards prepared in PBS were used for the assay technique. The validity of this procedure has been documented previously (24, 26) .
Standard curves were pooled because minimal variability was shown from plate to plate. Table 1 shows the consistency of the size ofzone of inhibition for cefamandole in the serum and central nervous system (CNS; CSF or brain). The zone of inhibition was then plotted against the logarithm of the antibiotic concentration, and the results were used to generate a computer program for the calculation of unknowns by the method of least squares. For ex- (3, 6, 13, 18, 30) .
The pharmacokinetics of cefamandole penetration into CSF and brain in control animals are shown in Table 2 . There was essentially complete exclusion of this antibiotic from the CSF throughout the experimental period. Brain penetration rose during the first 4 h of the infusion and remained relatively stable during the subsequent 4 h at a level 0.003 times the serum concentration.
Induction of an inflammatory response by intracisternal inoculation of pneumococci increased the absolute level of cefamandole in the CSF (Table 2) . Similarly, a greater-than-10-fold increase in the brain-to-serum ratio of cefamandole concentration was documented in h 1 of the infusion comparing intact and inflamed meninges. There was a progressive decline in the concentration of this antibiotic between h 2 and all subsequent hours of the experiments in both brain and CSF. Comparative data for 4-h infusions of all antibiotics studied in rabbits with noninflamed and inflamed meninges are shown in Table 3 . In control animals, cephalothin did not penetrate either the blood-CSF or the blood-brain barrier within the limits of detectability. In infected animals, hemoglobin contamination of the samples accounted for all antibiotic detected in two of three samples where levels were recorded; no cephalothin was detected in brain extracts.
Ampicillin penetrated both barriers to a greater degree than did any other antibiotic tested. An inflammatory meningeal response increased CSF penetration, but had minimal effect upon brain penetration. Penicillin levels increased markedly in both CSF and brain in response to the pneumococcal inflammatory stimulus, whereas tobramycin was detectable in each CSF sample but in none of the brain homogenates.
All antibiotics, in which detectable levels were recorded, showed enhanced penetration into CSF in the experimental meningitis model. Cephalothin levels never exceeded the minimum of detectability at 0.2 ,ug/ml. A comparison of the ratio of CSF to serum antibiotic levels in inflamed versus intact meninges showed a 57-fold increase in cefamandole penetration, which exceeded that for ampicillin (9.7), penicillin G (28.6), and tobramycin (8.6 ). An analysis of the ratios of brain to serum antibiotic levels in inflamed versus intact meninges revealed minimal change for cefamandole (1.4), ampicillin (0.6), and tobramycin (2.0), with the greatest effect documented for penicillin G (10.7).
CSF levels of cefamandole in excess of the MBC for the test organism (0.0625 utg/ml) were recorded for only 1 of 3 animals after 1 h of infusion, but were found in 10 of 12 animals with infusions of 2 h or longer. Brain levels in excess of the MBC were documented for all animals independent of the duration of infusion. CSF cultures were positive in six of nine animals infused for 3 h or less, but were negative in five of six animals infused 4 h or longer. The culture-positive animal in this latter group Table 4 is a comparison of cefamandole with other antibiotics in achieving bacteriological cure after 4-h infusions. Cefamandole compared favorably with ampicillin in this series (five of six animals cured after a 4-h infusion) and was superior to cephalothin (two of six cured). The culture-positive animals treated with ampicillin had both CSF (1.999 ,ug/ml) and brain (0.395 ,ug/ml) levels of antibiotic in excess of the MBC for the organism. Similarly, the therapeutic failure to penicillin had both CSF (0.167 pg/ ml) and brain (0.331 p,g/ml) levels in excess of the MBC. Among the culture-negative animals, there was only one bacteriological cure that dissociated brain and CSF levels. In this animal the brain level of cefamandole was 0.117 ,ug/ml (greater than the MBC), and the CSF level was 0.036 ,ug/ml (less than the MBC). DISCUSSION Several authors (21, 26, 29) including ourselves have noted wide animal-to-animal variation of serum levels achieved by the administration of antibiotics on the basis of weight. However, our data document minimal variability for an individual animal during constant infusion. Pharnacokinetic analysis of cefamandole and all other antibiotics is presented as compartmental ratios to minimize such variability.
Few previous workers have assessed brain penetration of antibiotics (11, 12, 24, 25, 33) , and none has assessed it in relation to pharmacokinetic, pathophysiological, and therapeutic considerations. An analysis of the brain and CSF as anatomically separate compartments, as well as a new knowledge of pharmacokinetics, suggests that continuous intravenous infusion may offer an advantage in the penetration of these barriers (9) . Whether therapeutic advantage may be gained in the clinical setting remains to be determined.
Hemoglobin contamination can be assessed visually to levels of 0.1 g/100 ml. However, even small quantities of blood in CSF could account for a large proportion of an antibiotic detected in nanogram quantities. Thus, the technique of Lowry and Hastings (14) was used to supplement visual inspection of samples. With brain homogenates, a significant amount of blood contamination can be eliminated by exsanguinating the animal prior to removal of the brain. On the other hand, neither the assessment of the effects of this procedure on tissue levels nor the dynamics of altered membrane permeability under these circumstances has been undertaken. Thus, brains were removed as quickly as possible and washed to remove surface blood contamination, and correction for hemoglobin contamination of the resulting homogenate was made by nephelometry. In only 6 of 84 measurements of the brain or CSF level of an antibiotic did the calculated blood correction exceed the amount determined by the zone of inhibition. Five of the six disparate values differed by less than 0.05 ,ug/ml.
Waterman et al. (32) have recently assessed the importance of time for an antibiotic to become bound in serum. These authors reported high concentrations of interstitial cefazolin during the equilibration phase between the intravascular and tissue spaces (32) . The data in Table 2 (34) . With inflamed meninges the highest brain penetration occurred during the first 2 h. A progressive decline followed through 8 h of infusion. Whether some of this decline may be attributed to the passage of the drug into the extrachoroidal CSF, while free drug in the serum was reduced by protein binding, remains to be documented. The potential effects of diminishing inflammatory response on barrier permeability in cotjunction with bacteriological cure must also be considered. Also, the relative importance ofbulk flow or active transport of this new cephalosporin out of CSF and back into the venous system, as previously observed with penicillin (31) and gentamicin (28) , has yet to be determined.
Both ampicillin and penicillin G penetrated the intact blood-CSF barrier. With ampicillin also, there were high concentrations of drug in brain tissue. Cephalothin and tobramycin were excluded by both barriers within the limits of detectability. However, of greater significance, cephalothin also failed to penetrate these barriers in detectable amounts in the presence of meningitis. Our results thus lend support to the growing data regarding therapeutic failures with this antibiotic (8, 16) .
Tobramycin appeared in the CSF but not in the brain in this experimental model of pneumococcal meningitis. Kaiser and McGee (10) first noted therapeutic failures in patients receiving parenteral aminoglycosides. They documented lumbar, cisternal, and ventricular levels below the MBC of the infecting organism in four of five cases (10) . Also, residual ventriculitis has been a complication related to inadequate antibiotic effect. Moellering and Fischer have observed the persistence of ventricular infection with Proteus morgagni while lumbar fluid was sterile. Levels in these compartments were 1.2 and 10.3 ,ug/ml, respectively, while the MBC for the infecting organism was 8 ,ug/ ml (17) . Thus, current recommendations for the use of these antibiotics in meningitis due to susceptible organisms include intrathecal (7) or, preferably, intraventricular (10) supplementation of parenteral administration. Finally, webs have been noted at postmortem examination secondary to the infectious process. These may alter CSF dynamics, reducing choroidal flow to the ventricles. One possible explanation for these therapeutic failures may be the inability to penetrate brain tissue, as documented here for tobramycin. This could minimize the potential of antibiotic addition to CSF via extrachoroidal CSF production, particularly in the lateral ventricles. It may also account for the development of abscesses within the cerebral substance during persistent, inadequately treated meningitis (1, 23).
In this model of pneumococcal meningitis, both ampicillin and penicillin reach levels in excess of the MBC for the test organism in brain and CSF. If these levels are valid criteria for assessing therapeutic efficacy, then cefamandole may be a potential alternative for the treatment of pneumococcal meningitis. Previous work supports CSF penetration by cefamandole in experimental meningitis due to Streptococcus pneumoniae (26) and Haemophilus influenzae (29) . In data reported here a bacteriological cure was attained with 4 h of infusion in five of six animals for both cefamandole and ampicillin and in two of three animals for penicillin G. Cephalothin failed to sterilize the spinal fluid in four of six animals under similar circumstances. However, the data presented here do not allow a clear distinction between the importance of CSF or brain levels, since culture positivity persisted in a limited number of animals when both CSF and brain tissue levels exceeded the MBC. Thus, additional factors such as time and local host defense mechanisms may play an as yet undefined role.
Extrapolation of these results to human meningitis should be done with care. The pathogenesis of the disease is different in humans. Fonnation and circulation of CSF differ between rabbits and humans (4) . Antibiotic penetration of the blood-CSF barrier was not correlated with leukocyte count here, nor has this been found in dogs (30) , but Thrupp and associates did find such a correlation in humans (30) . In this experimental meningitis model, however, cefamandole compared favorably with ampicillin and penicillin G in the penetration of both CSF and brain and resulted in a rapid bacteriological cure in a similar number of animals. Antibiotic penetration of the brain may be an additional relevant factor in determining therapeutic efficacy of antimicrobial agents in bacterial meningitis.
